LNTH News and Press, Lantheus Holdings Inc. From 05/04/23

2023-05-04 14:10:47 ET Lantheus ( NASDAQ: LNTH ) surges 15% on better-than-expected Q1 results, driven by PSMA PET with Pylarify and Definity's increasing utilization for diagnostic purposes. The company expects Q2 FY 2023 revenue to be between $300M to $310M, beating the ...

2023-05-04 11:49:20 ET Shares of Lantheus Holdings (NASDAQ: LNTH) were up more than 11% Thursday morning after the diagnostic imaging and nuclear medicine products company reported first-quarter earnings on Thursday. The healthcare stock is up more than 84% so far this year. ...

2023-05-04 10:00:25 ET Gainers: Soligenix ( SNGX ) +117% . ZimVie ( ZIMV ) +27% . Lantheus ( LNTH ) +14% . MiNK Therapeutics ( INKT ) +16% . Reviva Pharmaceuticals ( RVPH ) +10% . Losers: Sensus Healthcare ( SRTS ...

2023-05-04 07:21:18 ET Lantheus press release ( NASDAQ: LNTH ): Q1 Non-GAAP EPS of $1.47 beats by $0.18 . Revenue of $300.78M (+44.0% Y/Y) beats by $20.12M . Q2 Guidance: Revenue of $300M-$310M Adj EPS of $1.25-$1.33 FY23 Outlook: revenue of $1....

Worldwide revenue of $300.8 million for the first quarter 2023, representing an increase of 44.0% from the prior year period GAAP net loss of $2.8 million for the first quarter 2023, compared to GAAP net income of $43.0 million in the prior year period GAAP fully diluted net loss ...

2023-05-03 13:43:14 ET Lantheus ( NASDAQ: LNTH ) is scheduled to announce Q1 earnings results on Thursday, May 4th, before market open. The consensus EPS Estimate is $1.29 (+33.0% Y/Y) and the consensus Revenue Estimate is $280.66M (+34.4% Y/Y). Over the last 2 years, ...

2023-04-24 08:39:37 ET For further details see: Lantheus, POINT Biopharma receive FDA Fast Track status for prostate cancer candidate

BEDFORD, Mass. and INDIANAPOLIS, April 24, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find...

BEDFORD, Mass. and INDIANAPOLIS, April 24, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fig...

BEDFORD, Mass., April 20, 2023 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, May 4, 2023, to discuss its financial and operating results for the first quarte...